These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21119148)

  • 1. Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis.
    Dubicka B; Elvins R; Roberts C; Chick G; Wilkinson P; Goodyer IM
    Br J Psychiatry; 2010 Dec; 197(6):433-40. PubMed ID: 21119148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treated depression in adolescents: predictors of outcome at 28 weeks.
    Wilkinson P; Dubicka B; Kelvin R; Roberts C; Goodyer I
    Br J Psychiatry; 2009 Apr; 194(4):334-41. PubMed ID: 19336785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.
    Goodyer I; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    BMJ; 2007 Jul; 335(7611):142. PubMed ID: 17556431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).
    Wilkinson P; Kelvin R; Roberts C; Dubicka B; Goodyer I
    Am J Psychiatry; 2011 May; 168(5):495-501. PubMed ID: 21285141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
    Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
    J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Child and adolescent depression intervention overview: what works, for whom and how well?
    Maalouf FT; Brent DA
    Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):299-312, viii. PubMed ID: 22537728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetine.
    Melvin GA; Finnin L; Taffe J; Dudley AL; Klimkeit EI; Gordon MS; Tonge B
    Clin Child Psychol Psychiatry; 2019 Oct; 24(4):892-905. PubMed ID: 30638065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
    Bondar J; Caye A; Chekroud AM; Kieling C
    Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
    Davey CG; Chanen AM; Cotton SM; Hetrick SE; Kerr MJ; Berk M; Dean OM; Yuen K; Phelan M; Ratheesh A; Schäfer MR; Amminger GP; Parker AG; Piskulic D; Harrigan S; Mackinnon AJ; Harrison BJ; McGorry PD
    Trials; 2014 Nov; 15():425. PubMed ID: 25370185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis.
    Dubicka B; Hadley S; Roberts C
    Br J Psychiatry; 2006 Nov; 189():393-8. PubMed ID: 17077427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.